Pharmacokinetics and Pharmacodynamics of Ticagrelor in Patients With Stable Angina, NSTEMI and STEMI Undergoing PCI

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.

Also called NCT02012140

  • Study
  • In this atlas

Overview

Design
Interventional study; non-randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 200 participants (planned count) (from the registry)
Sponsor
LifeBridge Health (from the registry)
Registry
  • NCT NCT02012140
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
Not reported
Countries
United States (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02012140. Non-randomized; no masking; primary purpose treatment. Start 2014-01 (registry gives no type); primary completion 2015-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Pharmacokinetics and Pharmacodynamics of Ticagrelor in Patients With Stable Angina, NSTEMI and STEMI Undergoing PCI
Condition
Cardiovascular Disease
Condition
Stable Angina
Intervention (Drug)
ticagrelor
Lead sponsor
LifeBridge Health (class: other)

Record details

Record id
cardio:ct-nct02012140
Content hash
71434b8bdfb8cf69a2face7b989b60ea7987ebac9057838eabf66319e40cb79d